retatrutide cardiovascular effects What is known about the safety of in adults with obesity and type 2 diabetes, and how should it be used in patients with existing cardiovascular disease? A study of Lilly's retatrutide

36 KimS.LeeJ.OhS

48 MORE INFORMATION IS NEEDED The newfound potential effects of GLP-1 RAs across numerous ophthalmic diseases have sparked excitement, concern, and confusion among ophthalmologists and patients alike

despite elevated or normal GIP secretion, its insulinotropic efficacy declines

Shaw will let you know what to expect from the medication once your goals are evaluated in a consultation

MCT oil is extracted from food sources of MCTs, the most prevalent source being coconut oil

While the benefits of the weight loss associated with GLP-1 agonist therapy can no longer be denied, it remains the case that a significant amount of that weight loss comes from loss of muscle